Skip to content

Comparative effect of Pippalyadi and Punarnava Anjan in Managing nearsightedness.

A RANDOMIZED COMPARATIVE CLINICAL TRIAL TO EVALUATE THE EFFICACY OF PIPPALYADI ANJAN AND PUNARNAVA ANJAN IN THE MANAGEMENT OF PRATHAMPATALGAT TIMIR W.S.R TO SIMPLE MYOPIA. - Nil

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/111665
Enrollment
60
Registered
2026-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

None listed

Sponsors

DrKshitija Kashinath Fand
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients having dioptic power -0.25D to -5D. 2)Signs & symptoms of simple myopia i.e, blurred vision,headache,eye strain. 3)Patient fit for Anjana Vidhi.

Exclusion criteria

Exclusion criteria: 1)k/c/o Pathological myopia, high myopia with degenerative and gross retinal changes. 2)Myopia associated with neighbouring structural deformities like corneal opacity. 3)Patients suffering from any of the systemic disorders DM, HTN. 4)Patients who have underwent any of the refractive surgeries. 5)Patients who are contraindicated for anjana procedure.

Design outcomes

Primary

MeasureTime frame
Reduction in sign and symptoms of Prathampatalgata Timira. Blurred vision,eye strain,headache.Timepoint: 1.Total duration of treatment-4 weeks 2.Assesment on 14th and 28th day.

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDrRekha Jori

SST Ayurved Mahavidyalaya ,Sangamner

drrekhamatkar1912@gmail.com9503197787

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026